Peter L. Hoang, President and CEO at Marker Therapeutics, Inc. (MRKR), bought 10,000 shares at $4.62 ($46K) on 2019-08-14, disclosed to the SEC on 2019-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.